Why the study?
Does serum glutamic oxaloacetic transaminase (SGO-T) activity differentiate myocardial necrosis from coronary insufficiency, pericarditis, and pulmonary infarction?
Does serum glutamic oxaloacetic transaminase (SGO-T) activity differentiate myocardial necrosis from coronary insufficiency, pericarditis, and pulmonary infarction?
Answers are grounded in this paper and cite their sources.
SGO-T activity is a valuable biomarker for differentiating myocardial necrosis from other causes of chest pain such as coronary insufficiency, pericarditis, and pulmonary infarction.
Previous studies have demonstrated consistent rises in serum activity of the enzyme, glutamic oxaloacetic transaminase (SGO-T), following myocardial necrosis of various etiologies. The present study demonstrates markedly different findings in experimental and clinical coronary insufficiency, pericarditis, and pulmonary infarction unless concomitant myocardial necrosis was present. This seems to be a valuable means of differentiating clinical problems in which the presence of myocardial injury is suspected as the basis of the patient's chest pain.
No takes yet. Share an insight, caveat, or question.
Nydick et al. (1957) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: